Acamprol Tablet
By Acamprol
Rx
6 Tablet in a Strip

Composition
Acamprosate(333mg)

Manufacturer - Sun Pharmaceutical Industries Ltd
Plot no 107/108,Namli block , Ranipool, East Sikkim 737135

Expires on or after
April, 2026

liver
Caution should be exercised when using Acamprol Tablet in individuals with severe liver disease. It may be necessary to adjust the dosage of the medication, so it is crucial to seek advice from your healthcare provider before starting treatment. There is limited data on the use of Acamprol Tablet in individuals with liver issues, but no dose adjustment is typically required for those with mild to moderate liver disease.

kidney
Acamprol Tablet should be used carefully in patients with kidney disease. A dose adjustment may be necessary, so it's important to consult your doctor. Avoid using this tablet if you have severe kidney disease.

alcohol
Consult your doctor when consuming alcohol with Acamprol Tablet.

driving
Acamprol Tablet typically does not impact driving ability.

pregnancy
Acamprol Tablet may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will consider the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Acamprol Tablet is considered safe during breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | Organosulfonic Acid |
Therapeutic Class | - |
Action Class | Alcohol deaddiction |
₹114
Inclusive of all taxes
Content verified by

Dr. Monie Riju Simon
MBBS - General Medicine
Last update on 11-Feb-2025